These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28183793)

  • 1. Clinical information has low sensitivity for postmortem diagnosis of heart valve disease.
    Coffey S; Harper AR; Cairns BJ; Roberts IS; Prendergast BD
    Heart; 2017 Jul; 103(13):1031-1035. PubMed ID: 28183793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.
    Coffey S; Cox B; Williams MJ
    Am Heart J; 2014 Apr; 167(4):562-567.e2. PubMed ID: 24655706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of people with valvular heart disease in a large, English community-based cohort study.
    Taylor CJ; Ordóñez-Mena JM; Jones NR; Roalfe AK; Myerson SG; Prendergast BD; Hobbs FR
    Heart; 2021 Aug; 107(16):1336-1343. PubMed ID: 34031157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing causes of heart valve disease mortality in New Zealand from 1988 to 2007.
    Coffey S; Cox B; Williams MJ
    N Z Med J; 2016 Jan; 129(1428):56-65. PubMed ID: 26914193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients.
    Gardezi SKM; Myerson SG; Chambers J; Coffey S; d'Arcy J; Hobbs FDR; Holt J; Kennedy A; Loudon M; Prendergast A; Prothero A; Wilson J; Prendergast BD
    Heart; 2018 Nov; 104(22):1832-1835. PubMed ID: 29794244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valvular Heart Disease Epidemics.
    Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
    J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older.
    Rezzoug N; Vaes B; de Meester C; Degryse J; Van Pottelbergh G; Mathei C; Adriaensen W; Pasquet A; Vanoverschelde JL
    BMC Cardiovasc Disord; 2016 Jan; 16():7. PubMed ID: 26754575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endocarditis in sudden cardiac death: highlighting the value of the autopsy, pathological features and cardiac complications.
    Cooper STE; Westaby JD; Griffin KJ; Sheppard MN
    Cardiovasc Pathol; 2021; 50():107292. PubMed ID: 32950709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtypes of atrial fibrillation with concomitant valvular heart disease derived from electronic health records: phenotypes, population prevalence, trends and prognosis.
    Banerjee A; Allan V; Denaxas S; Shah A; Kotecha D; Lambiase PD; Joseph J; Lund LH; Hemingway H
    Europace; 2019 Dec; 21(12):1776-1784. PubMed ID: 31408153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
    Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
    J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
    Bisson A; Bodin A; Clementy N; Bernard A; Babuty D; Lip GYH; Fauchier L
    Int J Cardiol; 2018 Jun; 260():93-98. PubMed ID: 29540261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle patterns, genetic susceptibility, and risk of valvular heart disease: a prospective cohort study based on the UK Biobank.
    Jia C; Zeng Y; Huang X; Yang H; Qu Y; Hu Y; Chen W; Yang X
    Eur J Prev Cardiol; 2023 Oct; 30(15):1665-1673. PubMed ID: 37259902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study.
    Huang X; Dhruva SS; Yuan X; Bai X; Lu Y; Yan X; Liu J; Li W; Hu D; Ji R; Gao M; Miao F; Li J; Ge J; Krumholz HM; Li J
    BMJ Open; 2021 Nov; 11(11):e052946. PubMed ID: 34732492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of hospitalized patients with valvular heart disease: Experience of a tertiary center.
    Esteves AF; Brito D; Rigueira J; Ricardo I; Pires R; Pedro MM; Veiga F; Pinto F
    Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):991-998. PubMed ID: 30554887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global epidemiology of valvular heart disease.
    Coffey S; Roberts-Thomson R; Brown A; Carapetis J; Chen M; Enriquez-Sarano M; Zühlke L; Prendergast BD
    Nat Rev Cardiol; 2021 Dec; 18(12):853-864. PubMed ID: 34172950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.